" Gambia trial opens over children's cough syrup deaths" 25 October 2023

A trial opened Tuesday in The Gambia's capital Banjul over the deaths last year of small children who took a cough syrup made by the India-based Maiden Pharmaceuticals. Some 70 children aged 5 and under died in 2022 after taking the over-the-counter medicines, leading to a national outcry in the West African nation of about 2.5 million people. Justice Ebrima Jaiteh of the High Court in Banjul adjourned the proceedings until November 7 after finding that three state defendants who had failed to appear "lacked diligence". Nineteen plaintiffs representing family members who died filed the civil suit in July, according to Salieu Taal, president of The Gambia Bar Association and one of the lawyers representing them. The families are suing five defendants -- Maiden Pharmaceuticals, local distributor Atlantic Pharmaceuticals, the Medical Controls Agency (MCA), the Ministry of Health and Attorney General Dawda A. Jallow -- to demand they admit that the children were killed by consuming contaminated medicines. They are also suing for an admission that the MCA failed in its statutory duty to regulate the quality and safety of medicines. They are demanding 15 million Dalasis (about $230,000) per child in damages. None of the five defendants were present on Tuesday.

The health ministry, MCA and attorney general requested a delay to the start of the trial, a motion the judge dimissed. He ordered the three to pay 10,000 Dalasis to the plaintiffs. The trial had already been delayed in July after the attorney general and health ministry claimed they had not been served subpoenas with adequate time to familiarise themselves with the lawsuit.